ArticleOncotarget2017

Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.

Kelli L Goss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.